Source: International Congress 2018 – Clinical determinants and biomarkers of COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
B. Alcazar Navarrete (Loja, Spain), O. Ruiz Rodriguez (Loja, Spain), P. Conde Baena (Loja, Spain), P. Romero Palacios (Granada, Spain). EOSINOPHIL COUNT AND FeNO AS PREDICTORS OF EXACERBACTIONS IN COPD. 2018

Member's Comments

No comment yet.

Related content which might interest you: BODE INDEX IN DIFFERENT PHENOTYPES OF COPD Source: International Congress 2017 – What is new in COPD diagnosis and classification? Year: 2017 TREATMENT-RELATED DETERMINANTS OF THE RESPIRATORY MICROBIOME IN COPD Source: Virtual Congress 2020 – Clinical studies of COPD: combination inhalers and much more Year: 2020 A MULTILATERAL APPROACH TO COPD COMORBIDITIES Source: International Congress 2018 – COPD and extrapulmonary comorbidities Year: 2018 BODY COMPOSITION ALTERATIONS AND ENDOTHELIAL DYSFUNCTION IN COPD AND HF. Source: International Congress 2019 – Cardiovascular comorbidities in COPD Year: 2019 ARE THERE DIFFERENCES IN EXERCISE CAPACITY BY GENDER IN COPD PATIENTES? Source: Virtual Congress 2020 – COPD phenotypes Year: 2020 RATES OF LUNG FUNCTION DECLINE DIFFERS BETWEEN COPD PHENOTYPES Source: Virtual Congress 2020 – COPD phenotypes Year: 2020 ASSESSMENT OF HEALTH-RELATED QUALITY OF LIFE IN DIFFERENT PHENOTYPES OF COPD Source: International Congress 2017 – Management of asthma in different situations Year: 2017 PERCEPTION OF CAREGIVERS ON THE CARE OF PATIENTS WITH COPD IN USE OF LTOT Source: International Congress 2017 – Nursing practice across respiratory care pathways Year: 2017 EVALUATION OF THE IMMUNOGLOBULIN G LEVEL AND THE GAMMAGLOBULIN FRACTION OF THE PROTEINOGRAM IN THE COPD EXACERBATOR PHENOTYPE Source: International Congress 2019 – Clinical aspects of airway diseases Year: 2019 THE EFFECT OF TIOTROPIUM ON EXACERBATIONS AND AIRFLOW IN PATIENTS WITH COPD. Source: Eur Respir J 2006; 27: 1076 Year: 2006 PRESERVED FORCED VITAL CAPACITY IS NOT ALWAYS REPRESENTING EARLY IPF Source: Virtual Congress 2020 – Clinical aspects of idiopathic pulmonary fibrosis Year: 2020 INFLUENCE OF INDUCED IMMUNOSUPRESSION ON INFLAMMATION AND LUNGS REMODELING ON THE COPD MODEL Source: International Congress 2019 – Cellular responses and cell therapy in lung injury and repair Year: 2019 NEUROMUSCULAR EFFICIENCY DURING EXERCISE IN COPD PATIENTS Source: International Congress 2019 – Exploring exercise responses in respiratory diseases Year: 2019 DOES THE BENEFIT FROM PULMONARY REHABILITATION DIFFER BETWEEN PHENOTYPES IN COPD? Source: Virtual Congress 2020 – Reviews and novel insights into pulmonary rehabilitation Year: 2020 IMPACT OF COMORBIDITY ON SLEEP QUALITY IN COPD PATIENTS EVALUATED WITH THE PITTSBURGH SLEEP QUALITY INDEX (PSQI) Source: International Congress 2018 – From continuous positive airway pressure (CPAP) and adherence to CPAP to asthma-COPD overlap syndrome (ACOS) Year: 2018 COPD DIAGNOSIS: DIFFERENCES ACCORDING GENDER Source: Virtual Congress 2021 – Primary care organisation and epidemiology Year: 2021 THE LEVEL OF SOLUBLE CD8 MOLECULES IN SERUM AND SPUTUM IN COPD PATIENTS WITH AN EXACERBATION Source: International Congress 2017 – Highlights on clinical problems in COPD Year: 2017 ASSOCIATION BETWEEN NEUTROPHIL AND PLATELET TO LYMPHOCYTE RATIO AND DISEASE SEVERITY IN STABLE COPD Source: Virtual Congress 2020 – Monitoring of patients with COPD Year: 2020 USEFULNESS OF MIRNAS AS PREDICTORS OF LUNG CANCER IN PATIENTS WITH COPD. A PILOT SUTDY Source: Virtual Congress 2021 – Mechanistic pathways in chronic and new lung diseases Year: 2021 IN-VITRO AEROSOL DEPOSITION OF VALVED HOLDING CHAMBERS FOR CHILDREN WITH BUDESONIDE pMDI Source: International Congress 2017 – Inhalers and their use Year: 2017